0001231919-26-000761.txt : 20260714 0001231919-26-000761.hdr.sgml : 20260714 20260714172935 ACCESSION NUMBER: 0001231919-26-000761 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260714 DATE AS OF CHANGE: 20260714 EFFECTIVENESS DATE: 20260714 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ImmunoVec, Inc. CENTRAL INDEX KEY: 0001914272 ORGANIZATION NAME: EIN: 850876916 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-590784 FILM NUMBER: 261175172 BUSINESS ADDRESS: STREET 1: 225 ARIZONA STREET, SUITE 200 CITY: SANTA MONICA STATE: CA ZIP: 90401 BUSINESS PHONE: 310-889-6225 MAIL ADDRESS: STREET 1: 225 ARIZONA STREET, SUITE 200 CITY: SANTA MONICA STATE: CA ZIP: 90401 D 1 primary_doc.xml X0708 D LIVE 0001914272 ImmunoVec, Inc. 3435 Wilshire Blvd Suite 2700-84 Los Angeles CA CALIFORNIA 90010 630-802-0139 DELAWARE Rarity Therapeutics, Inc. None Corporation true Ryan Wong 3435 Wilshire Blvd Suite 2700-84 Los Angeles CA CALIFORNIA 90010 Executive Officer Director William Woodward 3435 Wilshire Blvd Suite 2700-84 Los Angeles CA CALIFORNIA 90010 Executive Officer Director Douglass Lorenzen 3435 Wilshire Blvd Suite 2700-84 Los Angeles CA CALIFORNIA 90010 Executive Officer Director Promoter Chris Lucas 3435 Wilshire Blvd Suite 2700-84 Los Angeles CA CALIFORNIA 90010 Director Other Technology Decline to Disclose 06b false 2026-06-29 false true true true Preferred Stock and Common Stock issuable upon conversion thereof. Total Offering Amount and Total Amount Sold include conversion of the previously issued convertible securities. false 0 14999944 12705822 2294122 false 10 0 0 0 false ImmunoVec, Inc. /s/Ryan Wong Ryan Wong Chief Executive Officer 2026-07-14